Imagion Biosystems (ASX:IBX)
ASX announcement history & article coverage
Transparent by design.
Announcments by Imagion Biosystems (ASX:IBX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
IBX Investor Presentation
Cleansing Notice
Application for quotation of securities - IBX
Application for quotation of securities - IBX
Notification of cessation of securities - IBX
IBX Phase 2 Clinical Trial Update
Imagion Biosystems Advances Phase 1b/2 Trial for MagSense® HER2 Imaging Agent with CRO Agreements and Product Ready for Distribution
Change of Director's Interest Notices - RP, BM, NW
Appendix 4D and Half-yearly Financial Report
Cleansing Notice
Application for quotation of securities - IBX
Cleansing Notice
Application for quotation of securities - IBX
Results of General Meeting
Appendix 4C and Quarterly Activities Report - June 2026
Proposed issue of securities - IBX
Non-Dilutive Short-Term Funding Secured
Notice of General Meeting/Proxy Form
Imagion Extends Collaboration with Siemens Healthineers
Cleansing Notice
Application for quotation of securities - IBX
Change of Director's Interest Notices - RP, BM, NW
Notification regarding unquoted securities - IBX
Update - Proposed issue of securities - IBX
Proposed issue of securities - IBX
Proposed issue of securities - IBX
Proposed issue of securities - IBX
IBX Secures Firm Commitments for $3.75m for Clinical Trial
Imagion Biosystems raises $3.75m to fund Phase 1b/2 HER2 breast cancer clinical trial
Trading Halt
Notification of cessation of securities - IBX